These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 20135628)

  • 41. Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe.
    Gopalakrishnan A; Sievert M; Ruoho AE
    Mol Pharmacol; 2007 Dec; 72(6):1567-75. PubMed ID: 17766642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
    Pifl C; Rajput A; Reither H; Blesa J; Cavada C; Obeso JA; Rajput AH; Hornykiewicz O
    J Neurosci; 2014 Jun; 34(24):8210-8. PubMed ID: 24920625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.
    German CL; Baladi MG; McFadden LM; Hanson GR; Fleckenstein AE
    Pharmacol Rev; 2015 Oct; 67(4):1005-24. PubMed ID: 26408528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localization and expression of VMAT2 aross mammalian species: a translational guide for its visualization and targeting in health and disease.
    Schafer MK; Weihe E; Eiden LE
    Adv Pharmacol; 2013; 68():319-34. PubMed ID: 24054151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
    Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
    Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas.
    Freeby M; Ichise M; Harris PE
    Islets; 2012; 4(6):393-7. PubMed ID: 23221614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The vesicular monoamine transporter 2: an underexplored pharmacological target.
    Bernstein AI; Stout KA; Miller GW
    Neurochem Int; 2014 Jul; 73():89-97. PubMed ID: 24398404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.
    Schäfer MK; Hartwig NR; Kalmbach N; Klietz M; Anlauf M; Eiden LE; Weihe E
    Diabetologia; 2013 May; 56(5):1047-56. PubMed ID: 23404442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.
    Ugolev Y; Segal T; Yaffe D; Gros Y; Schuldiner S
    J Biol Chem; 2013 Nov; 288(45):32160-32171. PubMed ID: 24062308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The molecular chaperone Hsc70 interacts with the vesicular monoamine transporter-2.
    Requena DF; Parra LA; Baust TB; Quiroz M; Leak RK; Garcia-Olivares J; Torres GE
    J Neurochem; 2009 Jul; 110(2):581-94. PubMed ID: 19457116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.
    Peter D; Vu T; Edwards RH
    J Biol Chem; 1996 Feb; 271(6):2979-86. PubMed ID: 8621690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between polymorphisms in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) on chromosome 8p and schizophrenia.
    Lohoff FW; Weller AE; Bloch PJ; Buono RJ; Doyle GA; Ferraro TN; Berrettini WH
    Neuropsychobiology; 2008; 57(1-2):55-60. PubMed ID: 18451639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.
    Cliburn RA; Dunn AR; Stout KA; Hoffman CA; Lohr KM; Bernstein AI; Winokur EJ; Burkett J; Schmitz Y; Caudle WM; Miller GW
    J Chem Neuroanat; 2017 Oct; 83-84():82-90. PubMed ID: 27836486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors.
    Yao Z; Wei X; Wu X; Katz JL; Kopajtic T; Greig NH; Sun H
    Eur J Med Chem; 2011 May; 46(5):1841-8. PubMed ID: 21396745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2.
    Pidathala S; Liao S; Dai Y; Li X; Long C; Chang CL; Zhang Z; Lee CH
    Nature; 2023 Nov; 623(7989):1086-1092. PubMed ID: 37914936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing Vesicular Monoamine Transport and Toxicity Using Fluorescent False Neurotransmitters.
    Black CA; Bucher ML; Bradner JM; Jonas L; Igarza K; Miller GW
    Chem Res Toxicol; 2021 May; 34(5):1256-1264. PubMed ID: 33378168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
    Nickell JR; Krishnamurthy S; Norrholm S; Deaciuc G; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2010 Feb; 332(2):612-21. PubMed ID: 19855096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
    Hussain I; Bate GW; Henry J; Djali P; Dimaline R; Dockray GJ; Varro A
    J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):495-505. PubMed ID: 10332097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoamine transporter as a target molecule for psychostimulants.
    Sora I; Li B; Fumushima S; Fukui A; Arime Y; Kasahara Y; Tomita H; Ikeda K
    Int Rev Neurobiol; 2009; 85():29-33. PubMed ID: 19607959
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.